Literature DB >> 2060145

Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin.

T J Tunny1, R D Gordon, S A Klemm, D Cohn.   

Abstract

Fifteen patients with primary aldosteronism were classified as angiotensin II-unresponsive aldosterone-producing adenoma (AII-U APA, n = 9), or angiotensin II-responsive aldosterone-producing adenoma (AII-R APA, n = 6), based on the responsiveness of aldosterone to upright posture and to angiotensin II infusion. Lack of aldosterone response to angiotensin II infusion immediately postoperatively in the AII-R APA subtype was consistent with previous responsiveness residing solely within the adenoma. Cortisol levels in five of the six patients with AII-R APA failed to suppress normally with dexamethasone consistent with some autonomous production of cortisol by the adenoma. In contrast, cortisol levels suppressed normally during dexamethasone administration in all patients with AII-U APA. This biochemical distinction can be added to the previously described overproduction of 18-oxo cortisol in AII-U APA but not in AII-R APA. Histological examination of adenoma sections revealed predominantly (greater than or equal to 50%) zona fasciculata type cells in AII-U APA. In contrast, AII-R APA contained less than 20% zona fasciculata type. Thus, biochemical differences between AII-U APA and AII-R APA subtypes of primary aldosteronism may be due to underlying differences in cellular composition of the aldosterone-producing adenomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060145     DOI: 10.1111/j.1365-2265.1991.tb00306.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 2.  Primary aldosteronism in 2011: Towards a better understanding of causation and consequences.

Authors:  Michael Stowasser
Journal:  Nat Rev Endocrinol       Date:  2011-12-13       Impact factor: 43.330

3.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

Review 4.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 5.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

6.  Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

Authors:  Zeng Guo; Kazutaka Nanba; Aaron Udager; Brett C McWhinney; Jacobus P J Ungerer; Martin Wolley; Moe Thuzar; Richard D Gordon; William E Rainey; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

7.  Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

Authors:  Silvia Monticone; Isabella Castellano; Karine Versace; Barbara Lucatello; Franco Veglio; Celso E Gomez-Sanchez; Tracy A Williams; Paolo Mulatero
Journal:  Mol Cell Endocrinol       Date:  2015-05-06       Impact factor: 4.102

8.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

Review 9.  Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension.

Authors:  Morris J Brown
Journal:  JRSM Cardiovasc Dis       Date:  2012-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.